Director Assay Development

Lava Therapeutics seeks a new team member:

Director Assay Development

Lava Therapeutics (LAVA) is a start-up company that creates and develops next generation γδ T cell engaging bispecific antibodies for the curative treatment of cancer. LAVA started its operations in 2017 and is advancing its proprietary platform and pipeline of bispecific therapeutic antibodies, building on cutting-edge research originating from Dr. Hans van der Vliet’s group at the VU University Medical Center and Cancer Center Amsterdam. In 2018, LAVA raised EUR 16 million in its first major institutional financing round that will allow LAVA to develop a lead candidate for clinical testing and broaden its pipeline and bispecific γδ T cell engager platform. Expanding our team with new, talented, employees is key to LAVA’s future success. The company is based in ‘s Hertogenbosch in The Netherlands.

The position
As Director Assay Development you will direct all assay development at CROs, including binding, PK, ADA and potency assays and ensure assay availability required to support the preclinical and clinical development of LAVA’s compounds. In addition you will be responsible for QA at LAVA.

Qualified candidates will possess the following skills and experience:
MSc/PhD in Immunology, Pharmaceutical Sciences, Applied Sciences or related field
Strong analytical skills.
Extensive track record in assay development, assay qualification, assay transfer to CROs and quality assurance.
An innovative, goal-oriented, flexible and collaborative mindset
5-10+ years biotechnology industry experience
Authoring and reviewing of content for INDs/CTAs
Track record of success as evidenced by publication record and/or evidence of sustained contributions in a biotechnology or pharmaceutical setting.
Excellent communication skills and the ability to work as a team member
Proven ability to work with CROs/ CMOs/ external partners

Full time position
Permanent position after one year temporary contract
Salary and benefits according to biotech industry standards

T: +31 (0)73 627 4520-KvK 6533 5740-Onderwijsboulevard 225
5223 DE ’s Hertogenbosch
Responses to